Protocol DAL-PK-02: Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months with Suspected or Confirmed Bacterial Infection

Project: Research project

Project Details

StatusFinished
Effective start/end date2/14/165/10/18

Funding

  • Allergan Sales, LLC
  • Allergan Sales, LLC